ArticleInternational journal of clinical oncology2026
Conversion surgical after neoadjuvant immunochemotherapy achieves survival comparable to initially resectable disease in borderline resectable esophageal cancer.
Binwen Xu et al.PubMed ↗Publisher ↗
No numbers read from the abstract.